Intelligent Bio Solutions closes $2.55M public offering of common stock and warrants

INTELLIGENT BIO SOLUTIONS INC.

Sold 654,990 shares and warrants to purchase 196,497 shares at $3.90 per unit, including full over-allotment.
Gross proceeds of $2.55M; net proceeds for working capital and general corporate purposes.
Warrants exercisable immediately at $3.90/share, expire March 10, 2028.
Underwriter received Representative Warrants for 32,750 shares at $4.875/share, expiring March 8, 2028.
Common stock outstanding post-offering: 1,571,255 shares (assuming no warrant exercise).

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

INTELLIGENT BIO SOLUTIONS INC. entered into Underwriting Agreement with Ladenburg Thalmann & Co. Inc., as representative of the several underwriters valued at approximately $2.55 million (effective 2023-03-08).

Action: entry
Agreement: underwriting
Counterparty: Ladenburg Thalmann & Co. Inc., as representative of the several underwriters
Value: approximately $2.55 million
Effective: 2023-03-08

Exact text from the filing

On March 8, 2023, Intelligent Bio Solutions Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Ladenburg Thalmann & Co. Inc., as representatives (the “Representative”) of the several underwriters named in Schedule I thereto (collectively, the “Underwriters”), relating to an underwritten public offering of 569,560 shares

View on SEC.gov

Browse all material agreements →

INTELLIGENT BIO SOLUTIONS INC. filing history →

Source: SEC EDGAR

accession 0001493152-23-007271

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.